UK markets closed

Boston Scientific Corporation (BSX)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
73.69-0.41 (-0.55%)
At close: 04:00PM EDT
74.33 +0.64 (+0.87%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close74.10
Open74.20
Bid73.50 x 1000
Ask74.50 x 1100
Day's range73.54 - 74.30
52-week range48.35 - 74.39
Volume3,788,683
Avg. volume6,264,879
Market cap108.338B
Beta (5Y monthly)0.77
PE ratio (TTM)61.92
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • PR Newswire

    Boston Scientific Elects Dr. Cheryl Pegus to Board of Directors

    Boston Scientific Corporation (NYSE: BSX) announced today the election of Dr. Cheryl Pegus to its board of directors, effective immediately.

  • PR Newswire

    Boston Scientific Announces Results for First Quarter 2024

    Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.856 billion during the first quarter of 2024, growing 13.8 percent on a reported basis, 15.0 percent on an operational1 basis and 13.1 percent on an organic2 basis, all compared to the prior year period. The company reported GAAP net income attributable to Boston Scientific common stockholders of $495 million or $0.33 per share (EPS), compared to $300 million or $0.21 per share a year ago, and achieved adjusted3 EPS of $0.56 for

  • PR Newswire

    Boston Scientific Initiates NAVIGATE-PF Study of the FARAWAVE™ Nav Pulsed Field Ablation Catheter and FARAVIEW™ Software Module

    Boston Scientific Corporation (NYSE: BSX) has initiated the NAVIGATE-PF study of the FARAVIEW™ Software Module* when it is used to visualize and track the FARAWAVE™ Nav Pulsed Field Ablation (PFA) Catheter* for the treatment of patients with paroxysmal and persistent atrial fibrillation (AF). The FARAVIEW technology and the FARAWAVE Nav catheter expand the capabilities of the FARAPULSE™ PFA System through integration with our cardiac mapping system.